REACH Online
Call us now!
+44 870 8 200 310
Check out our new REACH compliance website! Get your SDS audited for free!
Write to a human
 
TITLE-II: REGISTRATION OF SUBSTANCES
CHAPTER-1: General obligation to register and information requirements
ARTICLE 11: Joint submission of data by multiple registrants
Lost in REACH? Not anymore! Try our new REACH Compliance Website
  • Assessment of REACH obligations
  • Letter of Access (LoA) negotiation
  • SDS authoring with 100% guarantee
  • REACH and CLP consulting
  • REACH Registration
  • REACH Compliance auditing
  • REACH Certificate and declaration
  • REACH Only Representative (ROR) services
ARTICLE 11: Joint submission of data by multiple registrants
1. When a substance is intended to be manufactured in the Community by one or more manufacturers and/or imported by one or more importers, and/or is subject to registration under Article 7, the following shall apply.
Subject to paragraph 3, the information specified in Article 10(a)(iv), (vi), (vii) and (ix), and any relevant indication under Article 10(a)(viii) shall first be submitted by the one registrant acting with the agreement of the other assenting registrant(s) (hereinafter referred to as the lead registrant).
Each registrant shall subsequently submit separately the information specified in Article 10(a)(i), (ii), (iii) and (x), and any relevant indication under Article 10(a)(viii).
The registrants may decide themselves whether to submit the information specified in Article 10(a)(v) and (b) and any relevant indication under Article 10(a)(viii) separately or whether one registrant is to submit this information on behalf of the others.
2. Each registrant need only comply with paragraph 1 for items of information specified in Article 10(a)(iv), (vi), (vii) and (ix) that are required for the purposes of registration within his tonnage band in accordance with Article 12.
3. A registrant may submit the information referred to in Article 10(a)(iv), (vi), (vii) or (ix) separately if:
(a) it would be disproportionately costly for him to submit this information jointly; or
(b) submitting the information jointly would lead to disclosure of information which he considers to be commercially sensitive and is likely to cause him substantial commercial detriment; or
(c) he disagrees with the lead registrant on the selection of this information.
If points (a), (b) or (c) apply, the registrant shall submit, along with the dossier, an explanation as to why the costs would be disproportionate, why disclosure of information was likely to lead to substantial commercial detriment or the nature of the disagreement, as the case may be.
4. A submission for registration shall be accompanied by the fee required in accordance with Title IX.
Referred by:
ARTICLE 4: General provision
ARTICLE 21: Manufacturing and import of substances
ARTICLE 22: Further duties of registrants
ARTICLE 41: Compliance check of registrations
ARTICLE 74: Fees and charges
ARTICLE 77: Tasks
ARTICLE 114: Classification and labelling inventory
ARTICLE 117: Reporting
ARTICLE VI: INFORMATION REQUIREMENTS REFERRED TO IN ARTICLE 10